Substance-Related Disorders in Adults

Disease-a-Month

Volumn 53, Issue 6, 2007, Pages 313-335

  Leikin, Jerrold B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL; AMANTADINE; BACLOFEN; BENZODIAZEPINE; CAFFEINE; CHLORDIAZEPOXIDE; CITALOPRAM; COCAINE; CYPROHEPTADINE; DANTROLENE; DESIPRAMINE; DIAZEPAM; DISULFIRAM; FLUMAZENIL; FLUOXETINE; HALOPERIDOL; LORAZEPAM; NALMEFENE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE; PENTOBARBITAL; PHENOBARBITAL; PROPOFOL; THIAMINE; TIAGABINE; TRAZODONE; UNINDEXED DRUG;

ABDOMINAL PAIN; ADDICTION; AGITATION; ALCOHOL ABSTINENCE; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; CANNABIS ADDICTION; CLINICAL FEATURE; COCAINE DEPENDENCE; COMA; DELIRIUM TREMENS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG OVERDOSE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; KORSAKOFF PSYCHOSIS; LIVER FUNCTION; MUSCLE HYPOTONIA; NAUSEA; PSYCHOTHERAPY; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SMOKING CESSATION; SUBSTANCE ABUSE; TACHYCARDIA; TOBACCO DEPENDENCE; TREMOR; VOMITING; WERNICKE ENCEPHALOPATHY; WITHDRAWAL SYNDROME;

ADULT; ANTISOCIAL PERSONALITY DISORDER; ANXIETY DISORDERS; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; OVERDOSE; PRESCRIPTIONS, DRUG; RISK FACTORS; STREET DRUGS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 34447559701     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2007.04.001     Document Type: Review

References (21)

1. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., revised (1994), American Psychiatric Press, Washington, D.C
2. Petty T.L. The early diagnosis of lung cancer. Disease-a-Month 47 6 (2001) 204-258
3. Lasser K., Boyd J.W., Woolhandler S., et al. Smoking and mental illness: a population-based prevalence study. JAMA 284 20 (2000) 2606-2610
4. Olmedo R., and Hoffman R.S. Withdrawal syndromes. Emerg Med North Am 18 2 (2000) 273-288
5. Olmedo R.E., Nelson L., Howland M., et al. Propofol safely controls delirium tremens. J Toxicol Clin Toxicol 38 5 (2000) 537
6. Foy A. The pathophysiology, diagnosis and management of alcohol withdrawal. J Toxicol Clin Toxicol 38 2 (2000) 189-190
7. Addolorato G., Leggio L., Abenavoli L., et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 119 3 (2006) 276
8. Leggio L., Abenavoli L., Caputo F., et al. Baclofen use in the treatment of alcohol delirium tremens. Arch Intern Med 165 5 (2005) 586
9. Meythaler J.M., Roper J.F., and Brunner R.C. Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil 84 5 (2003) 638-642
10. Juliano L.M., and Griffiths R.R. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated feature. Psychopharmacol 176 1 (2004) 1-29
11. O'Connor P.G., and Kosten T.R. Rapid and ultrarapid opioid detoxification techniques. JAMA 279 3 (1998) 229-234
12. Dyer J.E., Roth B., and Hyma B.A. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 37 2 (2001) 147-153
13. Craig K., Gomez H.F., McManus J.L., et al. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J Emerg Med 18 1 (2000) 65-70
14. Mullins M.E., and Fitzmaurice S.C. Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal. J Emerg Med 20 (2001) 418-419
15. Sivilotti M.L., Burns M.J., and Aaron C.K. Pentobarbital for control of acute delirium due to gamma-butyrolactone withdrawal. Ann Emerg Med 35 5 (2000) S52-S53
16. Carbone J.R. The neuroleptic malignant and serotonin syndromes. Emerg Med Clin North Am 18 2 (2000) 317-325
17. Zajecka J., Tracy K.A., and Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psych 58 7 (1997) 291-297
18. Khazaal Y. Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder. Ann Pharmacother 41 (2007) 359-360
19. Schechter J.O. Treatment of disequilibrium and nausea in the SSRI discontinuation syndrome. J Clin Psychiatry 59 8 (1998) 431-432
20. Calfee R., and Fadale P. Popular ergogenic drugs and supplements in young athletes. Psychopharmacology (Berl) 176 1 (2004) 1-29
21. In: Gelenberg A.L., and Bassuk E.L. (Eds). The Practitioners Guide to Psychoactive Drugs. 4th ed. (1997), Plenum Medical Book Co, New York, NY 291-363